glasdegib
Showing 1 - 11 of 11
Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,
Recruiting
- Acute Myelogenous Leukemia (AML) Due to Therapy
- Acute Myeloid Leukemia With Myelodysplasia-Related Changes
- Glasdegib
- CPX-351
-
Orange, California
- +2 more
Nov 30, 2022
Acute Myeloid Leukemia Trial in Heidelberg (Gemtuzumab Ozogamicin 147, Gemtuzumab Ozogamicin 1, Glasdegib)
Terminated
- Acute Myeloid Leukemia
- Gemtuzumab Ozogamicin 147
- +3 more
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital Heidelberg, Internal Medicine V
Jun 27, 2022
Sclerodermoid Chronic GVHD (Disorder) Trial in Spain (Glasdegib)
Active, not recruiting
- Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
- Glasdegib
-
Barcelona, Spain
- +5 more
Mar 16, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Worldwide (Glasdegib, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +2 more
- Glasdegib
- Azacitidine
-
Salzburg, Austria
- +17 more
Dec 14, 2022
ACUTE MYELOID LEUKEMIA Trial in New Haven (Glasdegib, Decitabine)
Terminated
- ACUTE MYELOID LEUKEMIA
- Glasdegib
- Decitabine
-
New Haven, ConnecticutYale Cancer Center/Smilow
Sep 18, 2021
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody
Active, not recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Anti-OX40 Agonist Monoclonal Antibody PF-04518600
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 25, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)
Completed
- Leukemia, Myeloid, Acute
- glasdegib
- +5 more
-
Los Angeles, California
- +148 more
Jan 24, 2022
Healthy Volunteers Trial in New Haven (Glasdegib, High Fat, High Calorie Meal, Rabeprazole)
Completed
- Healthy Volunteers
- Glasdegib
- +2 more
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Jul 28, 2017
Healthy Volunteers Trial in New Haven (Glasdegib, Rifampin)
Completed
- Healthy Volunteers
- Glasdegib
- Rifampin
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Jun 24, 2015